| Company Name |
BSE Code |
Date |
Purpose |
|
|
 Bata India
|
500043 |
27-Oct-25 |
Bata India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2025 inter alia to consider and approve the Unaudited (Standalone and Consolidated) Financial Results for the quarter and half year ended September 30 2025 |
|
C P C L
|
500110 |
27-Oct-25 |
Chennai Petroleum Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2025 ,inter alia, to consider and approve Intimation of Board Meeting scheduled on 27.10.2025 (Monday) to consider and approve the Financial results for the Quarter ended 30.09.2025 (Q2)
|
|
Raymond
|
500330 |
27-Oct-25 |
Raymond Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2025 ,inter alia, to consider and approve Unaudited Financial Results (Standalone and Consolidated) of the Company for the Quarter and half year ended September 30, 2025
|
|
Welspun Special.
|
500365 |
27-Oct-25 |
Welspun Specialty Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2025 inter alia to consider and approve the unaudited financial results for the quarter and half year ended Sept 30 2025. |
|
Tata Inv.Corpn.
|
501301 |
27-Oct-25 |
Tata Investment Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2025 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and year ended September 30 2025. |
|
SRF
|
503806 |
27-Oct-25 |
SRF Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2025 inter alia to consider and approve A meeting of the Board of Directors is scheduled to be held on Monday 27th October 2025 for inter-alia
considering and approving the un-audited financial results for the quarter and half year ended 30th September 2025.
Pursuant to the Code of Conduct to Regulate Monitor and Report Trading by Insiders framed in accordance with the Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 the window for trading in the shares of the Company by the Designated Persons & Directors will remain closed between Wednesday 1st October 2025 to Wednesday 29th October 2025 (both days inclusive). |
|
Supreme Inds.
|
509930 |
27-Oct-25 |
Supreme Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2025 inter alia to consider and approve Unaudited Financial Results for Quarter and Half year ended 30th September 2025. |
|
Sylph Techno
|
511447 |
27-Oct-25 |
Sylph Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2025 inter alia to consider and approve Intimation of meeting of the Board of Directors under the Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015. |
|
Oswal Yarns
|
514460 |
27-Oct-25 |
Oswal Yarns Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2025 inter alia to consider and approve and take on records the Un-audited Standalone financial Results for the quarter and half year ended 30th September 2025. |
|
D & H India
|
517514 |
27-Oct-25 |
D & H India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2025 inter alia to consider and approve Dear Sir/Madam
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and other applicable rules and regulations as amended from time to time Notice is hereby given that a meeting of the Board of Directors of the Company is scheduled to be held on Monday 27th October 2025 inter-alia to consider the following:-
1. To consider and approve all the matters related to proposal of fund raising by way of equity shares or other securities of the Company through a rights issue subject to such regulatory/statutory approvals as may be required and as may be deemed appropriate by the Board.
2. Other Routine Agenda Items and any other matter with the permission of the Chair. |